Co-Authors
This is a "connection" page, showing publications co-authored by Mary Ramsay and Nick Andrews.
Connection Strength
1.944
-
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. N Engl J Med. 2021 08 12; 385(7):585-594.
Score: 0.239
-
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021 05 13; 373:n1088.
Score: 0.236
-
The impact of social and physical distancing measures on COVID-19 activity in England: findings from a multi-tiered surveillance system. Euro Surveill. 2021 03; 26(11).
Score: 0.233
-
All-cause excess mortality observed by age group and regions in the first wave of the COVID-19 pandemic in England. Euro Surveill. 2020 Jul; 25(28).
Score: 0.223
-
Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006-2018. Vaccine. 2019 07 26; 37(32):4491-4498.
Score: 0.208
-
Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study. Lancet Public Health. 2018 02; 3(2):e82-e90.
Score: 0.187
-
Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design. Int J Epidemiol. 2021 08 30; 50(4):1124-1133.
Score: 0.060
-
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial. Lancet. 2021 09 04; 398(10303):856-869.
Score: 0.060
-
An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021. Euro Surveill. 2021 07; 26(27).
Score: 0.060
-
Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England. J Infect. 2021 07; 83(1):104-111.
Score: 0.059
-
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. Lancet. 2021 05 08; 397(10286):1725-1735.
Score: 0.059
-
UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records. BMC Public Health. 2021 03 11; 21(1):484.
Score: 0.058
-
Influenza and Respiratory Virus Surveillance, Vaccine Uptake, and Effectiveness at a Time of Cocirculating COVID-19: Protocol for the English Primary Care Sentinel System for 2020-2021. JMIR Public Health Surveill. 2021 02 19; 7(2):e24341.
Score: 0.058
-
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. Lancet Infect Dis. 2020 09; 20(9):1034-1042.
Score: 0.055
-
Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England. JMIR Public Health Surveill. 2020 04 02; 6(2):e18606.
Score: 0.055
-
Inequalities in childhood vaccination timing and completion in London. Vaccine. 2018 10 29; 36(45):6726-6735.
Score: 0.049
-
Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015-2016. Emerg Infect Dis. 2017 07; 23(7):1184-1187.
Score: 0.045